Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.75 is 36% above its 5-year average of -8.93, near the high end of its 5-year range (-15.00–-2.60).
12.75% below its 12-month average of -5.10.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.40.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-5.75
EARNINGS PER SHARE (EPS) AVG TTM
-5.10
EARNINGS PER SHARE (EPS) AVG 3Y
-9.55
EARNINGS PER SHARE (EPS) AVG 5Y
-8.93
EARNINGS PER SHARE (EPS) AVG 10Y
-9.00
EARNINGS PER SHARE (EPS) AVG 15Y
-10.20
EARNINGS PER SHARE (EPS) AVG 20Y
-9.91
CURRENT VS TTM AVG
-12.75%
CURRENT VS 3Y AVG
+39.79%
CURRENT VS 5Y AVG
+35.63%
CURRENT VS 10Y AVG
+36.11%
CURRENT VS 15Y AVG
+43.63%
CURRENT VS 20Y AVG
+41.95%
Cytosorbents Corporation
Market Cap
$12.60M
Earnings Per Share (EPS)
-5.75
TTM Avg
-5.10
3Y Avg
-9.55
5Y Avg
-8.93
Market Cap
$12.63M
Earnings Per Share (EPS)
-0.20
TTM Avg
-0.26
3Y Avg
-0.46
5Y Avg
-0.44
Market Cap
$12.54M
Earnings Per Share (EPS)
-0.79
TTM Avg
-0.84
3Y Avg
-2.55
5Y Avg
-4.78
Market Cap
$12.89M
Earnings Per Share (EPS)
-1.62
TTM Avg
-966.25
3Y Avg
-483.82
5Y Avg
-322.89
Market Cap
$12.94M
Earnings Per Share (EPS)
-4.56
TTM Avg
-22.43
3Y Avg
-71.26
5Y Avg
-107.32
Market Cap
$13.27M
Earnings Per Share (EPS)
-1.39
TTM Avg
-1.16
3Y Avg
-1.40
5Y Avg
-1.09
Market Cap
$11.84M
Earnings Per Share (EPS)
-0.47
TTM Avg
-0.74
3Y Avg
-0.71
5Y Avg
-0.50
Market Cap
$11.76M
Earnings Per Share (EPS)
-16.53
TTM Avg
-14.84
3Y Avg
-116.30
5Y Avg
-277.16
Market Cap
$13.45M
Earnings Per Share (EPS)
-11.33
TTM Avg
-17.89
3Y Avg
-30.77
5Y Avg
-41.73
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.60M | -5.75 | -5.10 | -9.55 | -8.93 |
| IRIDEX Corporation (IRIX)vs › | $12.63M | -0.20 | -0.26 | -0.46 | -0.44 |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | -0.79 | -0.84 | -2.55 | -4.78 |
| Lantern Pharma Inc. (LTRN)vs › | $12.89M | -1.62 | -966.25 | -483.82 | -322.89 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.94M | -4.56 | -22.43 | -71.26 | -107.32 |
| Optimi Health Corp. (OPTH)vs › | $13.27M | -1.39 | -1.16 | -1.40 | -1.09 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.84M | -0.47 | -0.74 | -0.71 | -0.50 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.76M | -16.53 | -14.84 | -116.30 | -277.16 |
| Passage Bio, Inc. (PASG)vs › | $13.45M | -11.33 | -17.89 | -30.77 | -41.73 |
| Biofrontera Inc. (BFRI)vs › | $11.55M | -0.60 | -2.13 | -4.47 | -13.49 |
Trailing EPS (TTM)
$-5.75
Forward EPS (Est.)
$-4.40
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.60 |
| 2024-12-31 | -7.60 |
| 2023-12-31 | -13.00 |
| 2022-12-31 | -15.00 |
| 2021-12-31 | -11.40 |
| 2020-12-31 | -4.00 |
| 2019-12-31 | -12.00 |
| 2018-12-31 | -11.20 |
| 2017-12-31 | -6.20 |
| 2016-12-31 | -9.40 |
| 2015-12-31 | -6.60 |
| 2014-12-31 | -13.00 |
| 2013-12-31 | -10.00 |
| 2012-12-31 | -9.20 |
| 2011-12-31 | -17.20 |
| 2010-12-31 | -14.80 |
| 2009-12-31 | -32.80 |
| 2008-12-31 | -60.00 |
| 2007-12-31 | -67.40 |
| 2006-12-31 | -157.40 |
| 2005-12-31 | -5.20 |
